-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

102. Regulation of Iron Metabolism: Poster III

Regulation of Iron Metabolism Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Leona Raskova Kafkova*, Zuzana Somikova*, Jana Kucerova, MSc*, Lenka Calabkova*, Pavla Luzna*, Jan Stetka*, Dana Simkova*, Dalibor Dolezal* and Vladimir Divoky, PhD

Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Daniel Garcia dos Santos, PhD1*, Matthias Schranzhofer, MSc, PhD1*, Nam Lok Chun, PhD2*, Amel Hamdi, PhD1* and Prem Ponka, MD, PhD, FCMA1

1Lady Davis Institute for Medical Research, Montreal, QC, Canada
2Chemical Biology Centre and Department of Chemistry, University of Hong Kong, Hong Kong, China

John D Phillips, PhD1, Colin P Farrell, MPH2*, Jessica Overbey, MS3*, Hetanshi Naik, BS4*, Gordon D. McLaren, M.D.5, Christine E McLaren, PhD6, Luming Zhou, PhD7* and Charles J. Parker, MD1

1Medicine/Hematology, University of Utah School of Medicine, Salt Lake City, UT
2Medicine/Hematology, University of Utah School of Medicine, Salt Lake City
3Population Health Science and Policy, Ichan School of Medicine, New York, NY
4Department of Genetics, Ichan School of Medicine, New York
5Hematology/Oncology Section, Department of Veterans Affairs Long Beach Healthcare System, Long Beach, CA
6Department of Epidemiology, University of California Irvine, Irvine, CA
7Pathology, University of Utah School of Medicine, Salt Lake City, UT

Nicola J Svenson, MSc, Undergraduate MSc Hons1*, Russell Patmore, MRCP FRCPath2, Heidi J Cox, MBBS, MSc, MSc, BSc Hons3*, James R Bailey, MA MBBS MRCP4* and Stephen Holding, BSc, PhD, FRCPath5*

1Department of Hematology, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom
2Queens Centre for Oncology and Hematology, Castle Hill Hospital, Hull, United Kingdom
3Department of Clinical Biochemistry, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom
4Queens Centre for Haematology and Oncology, Hull and East Yorkshire NHS Trust, Yorkshire, United Kingdom
5Department of Immunology, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom

Leah Ann Schmelkin, BS1, Matthew T Howard, MD2*, David P. Steensma, MD3, Mark D. Fleming, MD, DPhil4, Vilmarie Rodriguez, MD5, Shakila Khan, MD6, Naseema Gangat, MBBS7, Alexandra Wolanskyj, MD7 and Mrinal M Patnaik, MBBS7

1Mayo Clinic, Mayo Medical School, Rochester, MN
2Division of Hematopathology, Mayo Clinic, Rochester, MN
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Pathology, Boston Children's Hospital, Boston, MA
5Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN
6Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN
7Division of Hematology, Mayo Clinic, Rochester, MN

Michael Auerbach, MD1, Lilee Wong, MD2*, Jessica McClintock, MD2*, Steven Lenowitz, MD2*, Nicola London, MD2*, Sarah Auerbach, BBA3* and Samuel Smith, MD2*

1Auerbach Hematology and Oncology, Baltimore, MD
2Obstetrics and Gynecology, MedStar Franklin Square Medical Center, Baltimore, MD
3West Virginia School of Osteopathic Medicine, Lewisburg, WV

Evangelia Vlachodimitropoulou Koumoutsea, MBBS1*, John B Porter2*, Nichola Cooper, MD3,4, Bethan Psaila, MD5 and Martha Sola-Visner, MD6

1UCL, London, United Kingdom
2University College London, London, United Kingdom
3Department of Hematology, Imperial College, Hammersmith Hospital, London, United Kingdom
4Haematology, Hammersmith Hospital-Imperial College Healthcare NHS Trust, London, United Kingdom
5Imperial, London, United Kingdom
6Harvard University, Boston

Regine Grosse, MD1*, Suzan Acar2*, Bjoern Schoennagel, MD2*, Roland Fischer, PhD3*, Jin Yamamura, MD2*, Gritta Janka, MD, PhD4 and Peter Nielsen, MD4*

1University Medical Center Hamburg-Eppendorf/Pediatric and Adult Hematology and Oncology, University, Hamburg, Germany
2University Medical Center Hamburg-Eppendorf/Diagnostic and Interventional Radiology, University, Hamburg, Germany
3University Medical Center Hamburg-Eppendorf/Pediatric Hematology and Oncology, University, Hamburg, Germany
4University Medical Center Hamburg-Eppendorf/Department of Pediatric Hematology and Oncology, University, Hamburg, Germany

Namita Kumari, PhD*, Tatiana Ammosova, PhD* and Sergei Nekhai, PhD

Center for Sickle Cell Disease, Howard University, Washington, DC

Hoda M Hassab, MD1*, Wafaa A El-Neanaey, MD2*, Ghada M F El-Deriny, MD3* and Eman El-Mahy, MD3*

1Clinical Research Center, Faculty of Medicine, Alexandria University, Alexandria, Egypt
2Department of Clinical & Chemical Pathology, Faculty of Medicine, Alexandria University. Egypt, Alexandria, Egypt
3Department of Pediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Gaelle Tachon1*, Marie-Paule Roth, MD2*, Fabienne Calcoen1*, Celine Besson-Fournier, M.Sc2*, Michael Bismuth, MD3* and Patricia Aguilar-Martinez, MD, PhD1

1Laboratory of haematology, University Hospital of Montpellier, Montpellier, France
2Physiopathology center, Inserm U1043, Toulouse, France
3Digestive department, University Hospital of Montpellier, Montpellier, France

Mariko Noguchi-Sasaki, Ph.D.*, Yusuke Sasaki, Ph.D.*, Yukari Matsuo-Tezuka*, Mitsue Kurasawa*, Keigo Yorozu, Ph.D.* and Yasushi Shimonaka*

Product Research Department, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan

Florian Scotté1*, Kamel Laribi2*, Christian Gisselbrecht3, Dominique Spaeth4*, Emna Kasdaghli, MD5*, Hélène Albrand, MD5*, Eric Leutenegger6* and Isabelle Ray-Coquard7*

1Hôpital Européen Georges-Pompidou, Paris, France
2Centre Hospitalier, Le Mans, France
3Hôpital Saint-Louis, Paris, France
4Centre d'Oncologie de Gentilly, Nancy, France
5Hospira France, Meudon La Foret, France
6GECEM, Paris, France
7Centre Léon Bérard, Lyon, France

Michael Boxer, MD

Arizona Oncology Associates, Tucson, AZ

Michael Spino, PharmD1,2, John Connelly, PhD1*, Yu-Chung Tsang, PhD1,2*, Caroline Fradette, PhD1* and Fernando Tricta, MD1

1ApoPharma Inc., Toronto, ON, Canada
2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

*signifies non-member of ASH